What does CUSIP G1125A116 represent in this 13F holders report?

CUSIP G1125A116 is the security identifier for BIOTW - BIOTECH ACQUISITION COMPANY - *W EXP 11/30/202 used to aggregate holder disclosures.

How many institutions held BIOTW - BIOTECH ACQUISITION COMPANY - *W EXP 11/30/202 in Q1 2023?

No institutional holders were reported for BIOTW - BIOTECH ACQUISITION COMPANY - *W EXP 11/30/202 in Q1 2023; review adjacent reporting periods for trend context.

202 (BIOTW)

CUSIP: G1125A116

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class: Equity / *W EXP 11/30/202
Total 13F shares: 0
Share change: -6,452,296
Total reported value: $0
Number of holders: 0
Value change: -$658,535
Number of sells: 43

Quarterly Holders Quick Answers

What is CUSIP G1125A116?
CUSIP G1125A116 identifies BIOTW - BIOTECH ACQUISITION COMPANY - *W EXP 11/30/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q4 2022

Recent filing periods for CUSIP G1125A116:

Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021

BIOTECH ACQUISITION COMPANY - *W EXP 11/30/202 (BIOTW)

Q1 2023 13F Holders as of 31 Mar 2023

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of BIOTW - BIOTECH ACQUISITION COMPANY - *W EXP 11/30/202 as of Q1 2023.